Date of this Version
- Imaging contrast agents, administered intravenously, are diverse, can be used for diagnostic and therapeutic purposes, and have specific regulatory requirements and development considerations.
- Collaborative relationships between industry and academia may provide the best approach for the development of these agents.
- Additional opportunities for development and commercialization include software specific for the analysis of contrast-enhanced examinations.
- There are special considerations for each class of imaging contrast agents with regards to market growth and potential avenues for future development.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Didier, Ryne and Mankoff, David
"Development of Radiographic Contrast Agents for Diagnostic Imaging,"
Academic Entrepreneurship for Medical and Health Scientists: Vol. 1
, Article 12.
Available at: https://repository.upenn.edu/ace/vol1/iss3/12